Does APIXABAN Cause Mantle cell lymphoma? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Mantle cell lymphoma have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
5
Reports of Mantle cell lymphoma with APIXABAN
0.0%
of all APIXABAN reports
4
Deaths
2
Hospitalizations
How Dangerous Is Mantle cell lymphoma From APIXABAN?
Of the 5 reports, 4 (80.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Mantle cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Mantle cell lymphoma?
RITUXIMAB (352)
IBRUTINIB (321)
BORTEZOMIB (184)
LENALIDOMIDE (179)
VENETOCLAX (174)
CYCLOPHOSPHAMIDE (120)
CYTARABINE (114)
VINCRISTINE (112)
BENDAMUSTINE (109)
DOXORUBICIN (108)
Which APIXABAN Alternatives Have Lower Mantle cell lymphoma Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ